PepGen PEPG
NASDAQ PEPG
$3.11 -0.07 (-2.20%)
As of: Sep 4, 2026 · 3:59 PM EDT

PepGen (PEPG) Non-Current Assets (2021 - 2026)

PepGen (PEPG) posted Non-Current Assets of $22.0 million for Q1 2026, down 4.01% sequentially from $22.9 million in Q4 2025, and down 16.4% YoY from $26.3 million in Q1 2025.

Analysis

PepGen (PEPG) Non-Current Assets (2021 - 2026) Analysis & Trends

PepGen has reported Non-Current Assets for 6 years, with the latest figure at $22.0 million in Q1 2026.

  • Quarterly Non-Current Assets fell 16.4% year-over-year to $22.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $93.6 million (down 14.98% YoY) and the FY2025 annual result came in at $22.9 million, down 15.4% from the prior year.
  • Non-Current Assets eased to $22.0 million in Q1 2026 per PEPG's latest filing, from $22.9 million in the prior quarter.
  • Over five years, Non-Current Assets peaked at $32.6 million in Q1 2023 and troughed at $4.2 million in Q3 2022.
  • A 5-year average of $23.8 million and a median of $27.1 million in 2024 frame the typical range for Non-Current Assets.
  • The sharpest annual moves came in 2022 and 2026: Non-Current Assets soared 757.92% in 2022, then decreased 16.4% in 2026.
  • Over 5 years, Non-Current Assets stood at $31.4 million in 2022, then retreated by 3.13% to $30.4 million in 2023, then slipped by 10.71% to $27.1 million in 2024, then declined by 15.4% to $22.9 million in 2025, then dropped by 4.01% to $22.0 million in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $22.0 million, $22.9 million, and $23.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 14.88 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 23.28 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.15 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 294.93 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 1.96 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 938.60 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 18.06 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 468.65 Mn
10 PepGen 217.99 Mn 217.99 Mn - 21.07 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.07 Mn
Mar 31, 2026 22.02 Mn
Dec 31, 2025 22.94 Mn
Sep 30, 2025 23.85 Mn
Jun 30, 2025 24.76 Mn
Mar 31, 2025 26.35 Mn
Dec 31, 2024 27.12 Mn
Sep 30, 2024 27.87 Mn
Jun 30, 2024 28.73 Mn
Mar 31, 2024 29.38 Mn
Dec 31, 2023 30.37 Mn
Sep 30, 2023 31.18 Mn
Jun 30, 2023 31.71 Mn
Mar 31, 2023 32.57 Mn
Dec 31, 2022 31.36 Mn
Sep 30, 2022 4.21 Mn
Jun 30, 2022 4.32 Mn
Mar 31, 2022 6.21 Mn
Dec 31, 2021 3.66 Mn